市場調査レポート

商品コード

1285861

オーソバイオロジクス市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: 2023年04月30日 | 発行: Transparency Market Research

| ページ情報: 英文 237 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 908,424円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,378,704円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,848,984円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

オーソバイオロジクス市場- レポートの範囲

TMRの調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界市場の収益を提供します。また、2023年から2031年までの世界市場の複合年間成長率（CAGR %）も掲載しています。

当レポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

当レポートは、世界市場における競合情勢を詳しく掘り下げています。世界市場で活動している主要企業を特定し、さまざまな属性の観点からプロファイルしています。当レポートで紹介されている市場企業の属性は、会社概要、財務状況、最近の動向、SWOTです。

イントロダクションと定義
主な調査結果と開発
市場金額予測：製品別、2017-2031
- 同種移植片
- 異種移植片
- 合成骨移植片
  - ハイドロキシアパタイト
  - B-リン酸三カルシウム（B-TCP）
  - 二相性
  - 生体活性ガラス
  - その他
- 脱灰骨マトリックス（DBM）
- 関節内補充療法
- 多血小板血漿（PRP）
- 骨髄吸引濃縮物（BMAC）
- その他
市場魅力度分析：製品別

第7章世界市場の分析と予測：用途別

イントロダクションと定義
主な調査結果と開発
市場金額予測：用途別、2017-2031
- 脊椎固定術
- 傷痕修復
- 再建手術
- 骨折
- 変形性関節症
- 顎顔面および歯科用途
- その他
市場魅力分析：用途別

第8章世界市場の分析と予測：エンドユーザー別

イントロダクションと定義
主な調査結果と開発
市場金額予測：エンドユーザー別、2017-2031
- 病院
- 整形外科クリニック
- その他
市場魅力度分析：エンドユーザー別

第9章世界市場の分析と予測：地域別

主な調査結果
市場金額予測：地域別
- 北米
- 欧州
- アジア太平洋地域
- ラテンアメリカ
- 中東・アフリカ
市場魅力度分析：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東およびアフリカ市場の分析と予測

第15章競合情勢

市場企業-競合マトリックス（企業の階層および規模別）
市場シェア・ランキング分析：企業別、2022年
企業プロファイル
- Alphatec Spine, Inc.
- Arthrex
- Bioventus LLC
- Exactech, Inc.
- Global Medical, Inc.
- Integra Lifesciences
- Medtronic
- MTF Biologics
- RTI Surgical
- Sano Orthopedics
- Sanofi
- Seikagaku Corporation
- Stryker
- Zimmer Biomet

図表

List of Tables

Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by 2017-2031, by Application
Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America Orthobiologics Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 06: North America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 07: North America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 08: North America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 09: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 16: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 17: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 19: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 23: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 24: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Orthobiologics Market Value Share, by Product, 2021
Figure 03: Global Orthobiologics Market Value Share, by Application, 2021
Figure 04: Global Orthobiologics Market Value Share, by End-user, 2021
Figure 05: Global Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 06: Global Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
Figure 07: Global Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 08: Global Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
Figure 09: Global Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 10: Global Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 11: Global Orthobiologics Market Value Share Analysis, by Region, 2021 and 2031
Figure 12: Global Orthobiologics Market Attractiveness Analysis, by Region, 2023-2031
Figure 13: North America Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
Figure 14: North America Orthobiologics Market Value Share Analysis, by Country, 2021 and 2031
Figure 15: North America Orthobiologics Market Attractiveness Analysis, by Country, 2023-2031
Figure 16: North America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 17: North America Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
Figure 18: North America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 19: North America Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
Figure 20: North America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 21: North America Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 22: Europe Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
Figure 23: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 24: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 25: Europe Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 26: Europe Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
Figure 27: Europe Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 28: Europe Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
Figure 29: Europe Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 30: Europe Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 31: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
Figure 32: Asia Pacific Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 33: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 34: Asia Pacific Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 35: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
Figure 36: Asia Pacific Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 37: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
Figure 38: Asia Pacific Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 39: Asia Pacific Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 40: Latin America Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
Figure 41: Latin America Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 42: Latin America Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 43: Latin America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 44: Latin America Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
Figure 45: Latin America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 46: Latin America Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
Figure 47: Latin America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 48: Latin America Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 49: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
Figure 50: Middle East & Africa Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 51: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 52: Middle East & Africa Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031
Figure 53: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
Figure 54: Middle East & Africa Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031
Figure 55: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Application, 2023-2031
Figure 56: Middle East & Africa Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031
Figure 57: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 58: Company Share Analysis, 2021

Product Code: TMRGL1747

Orthobiologics Market - Scope of Report

TMR's report on the global Orthobiologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Orthobiologics Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Orthobiologics Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Orthobiologics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Orthobiologics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Orthobiologics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Orthobiologics market.

The report delves into the competitive landscape of the global Orthobiologics market. Key players operating in the global Orthobiologics Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Orthobiologics Market profiled in this report.

Key Questions Answered in Global Orthobiologics Market Report:

What is the sales/revenue generated by Orthobiologics across all regions during the forecast period?
What are the opportunities in the global Orthobiologics market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Orthobiologics Market - Research Objectives and Research Approach

The comprehensive report on the global Orthobiologics Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Orthobiologics Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Orthobiologics market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Orthobiologics Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Key Market Trends
5.2. Merger & Acquisition
5.3. Strategies of Top Five Players Operating in the Market
5.4. Incidence of Orthopedic Disorder, by Key Countries
5.5. Number of Surgical Procedures
5.6. Regulatory and Reimbursement Scenario by Key Countries
5.7. Covid-19 Pandemic Impact on the Industry

6. Global Orthobiologics Market Analysis and Forecast, by Product

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Allografts
- 6.3.2. Xenografts
- 6.3.3. Synthetic Bone Grafts
  - 6.3.3.1. Hydroxyapatite
  - 6.3.3.2. B-tricalcium Phosphate (B-TCP)
  - 6.3.3.3. BiPhasic
  - 6.3.3.4. Bioactive Glass
  - 6.3.3.5. Others
- 6.3.4. Demineralized Bone Matrix (DBM)
- 6.3.5. Viscosupplementation
- 6.3.6. Platelet-rich Plasma (PRP)
- 6.3.7. Bone Marrow Aspirate Concentrate (BMAC)
- 6.3.8. Others
6.4. Market Attractiveness Analysis, by Product

7. Global Orthobiologics Market Analysis and Forecast, by Application

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. Spinal Fusion
- 7.3.2. Trauma Repair
- 7.3.3. Reconstructive Surgeries
- 7.3.4. Fractures
- 7.3.5. Osteoarthritis
- 7.3.6. Maxillofacial & Dental Applications
- 7.3.7. Others
7.4. Market Attractiveness Analysis, by Application

8. Global Orthobiologics Market Analysis and Forecast, by End-user

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Orthopedic Clinics
- 8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user

9. Global Orthobiologics Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Orthobiologics Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
- 10.2.1. Allografts
- 10.2.2. Xenografts
- 10.2.3. Synthetic Bone Grafts
  - 10.2.3.1. Hydroxyapatite
  - 10.2.3.2. B-tricalcium Phosphate (B-TCP)
  - 10.2.3.3. BiPhasic
  - 10.2.3.4. Bioactive Glass
  - 10.2.3.5. Others
- 10.2.4. Demineralized Bone Matrix (DBM)
- 10.2.5. Viscosupplementation
- 10.2.6. Platelet-rich Plasma (PRP)
- 10.2.7. Bone Marrow Aspirate Concentrate (BMAC)
- 10.2.8. Others
10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. Spinal Fusion
- 10.3.2. Trauma Repair
- 10.3.3. Reconstructive Surgeries
- 10.3.4. Fractures
- 10.3.5. Osteoarthritis
- 10.3.6. Maxillofacial & Dental Applications
- 10.3.7. Others
10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals
- 10.4.2. Orthopedic Clinics
- 10.4.3. Others
10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
10.6. Market Attractiveness Analysis
- 10.6.1. By Product
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country

11. Europe Orthobiologics Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Allografts
- 11.2.2. Xenografts
- 11.2.3. Synthetic Bone Grafts
  - 11.2.3.1. Hydroxyapatite
  - 11.2.3.2. B-tricalcium Phosphate (B-TCP)
  - 11.2.3.3. BiPhasic
  - 11.2.3.4. Bioactive Glass
  - 11.2.3.5. Others
- 11.2.4. Demineralized Bone Matrix (DBM)
- 11.2.5. Viscosupplementation
- 11.2.6. Platelet-rich Plasma (PRP)
- 11.2.7. Bone Marrow Aspirate Concentrate (BMAC)
- 11.2.8. Others
11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. Spinal Fusion
- 11.3.2. Trauma Repair
- 11.3.3. Reconstructive Surgeries
- 11.3.4. Fractures
- 11.3.5. Osteoarthritis
- 11.3.6. Maxillofacial & Dental Applications
- 11.3.7. Others
11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Orthopedic Clinics
- 11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
- 11.6.1. By Product
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region

12. Asia Pacific Orthobiologics Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Allografts
- 12.2.2. Xenografts
- 12.2.3. Synthetic Bone Grafts
  - 12.2.3.1. Hydroxyapatite
  - 12.2.3.2. B-tricalcium Phosphate (B-TCP)
  - 12.2.3.3. BiPhasic
  - 12.2.3.4. Bioactive Glass
  - 12.2.3.5. Others
- 12.2.4. Demineralized Bone Matrix (DBM)
- 12.2.5. Viscosupplementation
- 12.2.6. Platelet-rich Plasma (PRP)
- 12.2.7. Bone Marrow Aspirate Concentrate (BMAC)
- 12.2.8. Others
12.3. Market Value Forecast, by Application, 2017-2031
- 12.3.1. Spinal Fusion
- 12.3.2. Trauma Repair
- 12.3.3. Reconstructive Surgeries
- 12.3.4. Fractures
- 12.3.5. Osteoarthritis
- 12.3.6. Maxillofacial & Dental Applications
- 12.3.7. Others
12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Orthopedic Clinics
- 12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
- 12.6.1. By Product
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region

13. Latin America Orthobiologics Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Allografts
- 13.2.2. Xenografts
- 13.2.3. Synthetic Bone Grafts
  - 13.2.3.1. Hydroxyapatite
  - 13.2.3.2. B-tricalcium Phosphate (B-TCP)
  - 13.2.3.3. BiPhasic
  - 13.2.3.4. Bioactive Glass
  - 13.2.3.5. Others
- 13.2.4. Demineralized Bone Matrix (DBM)
- 13.2.5. Viscosupplementation
- 13.2.6. Platelet-rich Plasma (PRP)
- 13.2.7. Bone Marrow Aspirate Concentrate (BMAC)
- 13.2.8. Others
13.3. Market Value Forecast, by Application, 2017-2031
- 13.3.1. Spinal Fusion
- 13.3.2. Trauma Repair
- 13.3.3. Reconstructive Surgeries
- 13.3.4. Fractures
- 13.3.5. Osteoarthritis
- 13.3.6. Maxillofacial & Dental Applications
- 13.3.7. Others
13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Orthopedic Clinics
- 13.4.3. Others
13.5. Market Value Forecast, by Country, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
- 13.6.1. By Product
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region

14. Middle East & Africa Orthobiologics Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Allografts
- 14.2.2. Xenografts
- 14.2.3. Synthetic Bone Grafts
  - 14.2.3.1. Hydroxyapatite
  - 14.2.3.2. B-tricalcium Phosphate (B-TCP)
  - 14.2.3.3. BiPhasic
  - 14.2.3.4. Bioactive Glass
  - 14.2.3.5. Others
- 14.2.4. Demineralized Bone Matrix (DBM)
- 14.2.5. Viscosupplementation
- 14.2.6. Platelet-rich Plasma (PRP)
- 14.2.7. Bone Marrow Aspirate Concentrate (BMAC)
- 14.2.8. Others
14.3. Market Value Forecast, by Application, 2017-2031
- 14.3.1. Spinal Fusion
- 14.3.2. Trauma Repair
- 14.3.3. Reconstructive Surgeries
- 14.3.4. Fractures
- 14.3.5. Osteoarthritis
- 14.3.6. Maxillofacial & Dental Applications
- 14.3.7. Others
14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals
- 14.4.2. Orthopedic Clinics
- 14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
- 14.6.1. By Product
- 14.6.2. By Application
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share/Ranking Analysis, by Company, 2022
15.3. Company Profiles
- 15.3.1. Alphatec Spine, Inc.
  - 15.3.1.1. Company Overview
  - 15.3.1.2. Product Portfolio
  - 15.3.1.3. SWOT Analysis
  - 15.3.1.4. Strategic Overview
- 15.3.2. Arthrex
  - 15.3.2.1. Company Overview
  - 15.3.2.2. Product Portfolio
  - 15.3.2.3. SWOT Analysis
  - 15.3.2.4. Strategic Overview
- 15.3.3. Bioventus LLC
  - 15.3.3.1. Company Overview
  - 15.3.3.2. Product Portfolio
  - 15.3.3.3. SWOT Analysis
  - 15.3.3.4. Strategic Overview
- 15.3.4. Exactech, Inc.
  - 15.3.4.1. Company Overview
  - 15.3.4.2. Product Portfolio
  - 15.3.4.3. SWOT Analysis
  - 15.3.4.4. Strategic Overview
- 15.3.5. Global Medical, Inc.
  - 15.3.5.1. Company Overview
  - 15.3.5.2. Product Portfolio
  - 15.3.5.3. SWOT Analysis
  - 15.3.5.4. Strategic Overview
- 15.3.6. Integra Lifesciences
  - 15.3.6.1. Company Overview
  - 15.3.6.2. Product Portfolio
  - 15.3.6.3. SWOT Analysis
  - 15.3.6.4. Strategic Overview
- 15.3.7. Medtronic
  - 15.3.7.1. Company Overview
  - 15.3.7.2. Product Portfolio
  - 15.3.7.3. SWOT Analysis
  - 15.3.7.4. Strategic Overview
- 15.3.8. MTF Biologics
  - 15.3.8.1. Company Overview
  - 15.3.8.2. Product Portfolio
  - 15.3.8.3. SWOT Analysis
  - 15.3.8.4. Strategic Overview
- 15.3.9. RTI Surgical
  - 15.3.9.1. Company Overview
  - 15.3.9.2. Product Portfolio
  - 15.3.9.3. SWOT Analysis
  - 15.3.9.4. Strategic Overview
- 15.3.10. Sano Orthopedics
  - 15.3.10.1. Company Overview
  - 15.3.10.2. Product Portfolio
  - 15.3.10.3. SWOT Analysis
  - 15.3.10.4. Strategic Overview
- 15.3.11. Sanofi
  - 15.3.11.1. Company Overview
  - 15.3.11.2. Product Portfolio
  - 15.3.11.3. SWOT Analysis
  - 15.3.11.4. Strategic Overview
- 15.3.12. Seikagaku Corporation
  - 15.3.12.1. Company Overview
  - 15.3.12.2. Product Portfolio
  - 15.3.12.3. SWOT Analysis
  - 15.3.12.4. Strategic Overview
- 15.3.13. Stryker
  - 15.3.13.1. Company Overview
  - 15.3.13.2. Product Portfolio
  - 15.3.13.3. SWOT Analysis
  - 15.3.13.4. Strategic Overview
- 15.3.14. Zimmer Biomet
  - 15.3.14.1. Company Overview
  - 15.3.14.2. Product Portfolio
  - 15.3.14.3. SWOT Analysis
  - 15.3.14.4. Strategic Overview

オーソバイオロジクス市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

オーソバイオロジクス市場- レポートの範囲

目次

第1章序文

第2章前提条件と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章世界市場の分析と予測：製品別

第7章世界市場の分析と予測：用途別

第8章世界市場の分析と予測：エンドユーザー別

第9章世界市場の分析と予測：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東およびアフリカ市場の分析と予測

第15章競合情勢

List of Tables

List of Figures

Orthobiologics Market - Scope of Report

Key Questions Answered in Global Orthobiologics Market Report:

Orthobiologics Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview

5. Key Insights

6. Global Orthobiologics Market Analysis and Forecast, by Product

7. Global Orthobiologics Market Analysis and Forecast, by Application

8. Global Orthobiologics Market Analysis and Forecast, by End-user

9. Global Orthobiologics Market Analysis and Forecast, by Region

10. North America Orthobiologics Market Analysis and Forecast

11. Europe Orthobiologics Market Analysis and Forecast

12. Asia Pacific Orthobiologics Market Analysis and Forecast

13. Latin America Orthobiologics Market Analysis and Forecast

14. Middle East & Africa Orthobiologics Market Analysis and Forecast

15. Competition Landscape

オーソバイオロジクス市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

オーソバイオロジクス市場- レポートの範囲

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

第5章 重要な洞察

第6章 世界市場の分析と予測：製品別

第7章 世界市場の分析と予測：用途別

第8章 世界市場の分析と予測：エンドユーザー別

第9章 世界市場の分析と予測：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東およびアフリカ市場の分析と予測

第15章 競合情勢

List of Tables

List of Figures

Orthobiologics Market - Scope of Report

Key Questions Answered in Global Orthobiologics Market Report:

Orthobiologics Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview

5. Key Insights

6. Global Orthobiologics Market Analysis and Forecast, by Product

7. Global Orthobiologics Market Analysis and Forecast, by Application

8. Global Orthobiologics Market Analysis and Forecast, by End-user

9. Global Orthobiologics Market Analysis and Forecast, by Region

10. North America Orthobiologics Market Analysis and Forecast

11. Europe Orthobiologics Market Analysis and Forecast

12. Asia Pacific Orthobiologics Market Analysis and Forecast

13. Latin America Orthobiologics Market Analysis and Forecast

14. Middle East & Africa Orthobiologics Market Analysis and Forecast

15. Competition Landscape

第1章序文

第2章前提条件と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章世界市場の分析と予測：製品別

第7章世界市場の分析と予測：用途別

第8章世界市場の分析と予測：エンドユーザー別

第9章世界市場の分析と予測：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東およびアフリカ市場の分析と予測

第15章競合情勢